Moreover, it has been reported that inhibition of RANKL by recombinant osteoprotegerin, a decoy receptor for RANKL, suppressed tumor bone metastasis and progression and improved survival in a mouse model [37]. This evidence concerns the gene TNFRSF11B and neoplasm.